Paxillin is a focal-adhesion associated protein implicated in the regulation of integrin signaling and organization of the actin cytoskeleton. Paxillin associates with numerous signaling molecules including adaptor molecules (p130Cas, CRK), kinases (FAK, Pyk2, PAK and SRC), tyrosine phosphatases (PTP ± PEST), ARF ± GAP proteins (p95pkl, PAG3) and papillomavirus E6 oncoproteins. Although paxillin is tyrosine phosphorylated in cellular processes such as cell attachment and spreading, little direct evidence is available about paxillin's role in these events. Targeted gene disruption was used to generate paxillin null mouse embryonic stem (ES) cells and paxillin null dierentiated cells. Paxillin null ES cells exhibit delayed spreading on integrin binding substrates ®bronectin and laminin, and there is reduced tyrosine phosphorylation of Focal Adhesion Kinase (FAK). Both of these phenotypes are recovered in paxillin knockout cells upon exogenous re-expression of paxillin. The individual LD motifs of paxillin that are binding sites for FAK, vinculin and ARF ± GAP proteins, as well as tyrosine residues that when phosphorylated create binding sites for CRK family members, are dispensable for FAK phosphorylation and early cell spreading. These results demonstrate that paxillin contributes to attachment-dependent tyrosine phosphorylation of FAK and early cell spreading in ES cells.
Introduction
Cell adhesion to extra cellular matrix (ECM) through the binding of cellular integrin receptors with ECM proteins initiates a tyrosine kinase signaling cascade that regulates multiple functions including cell attachment, spreading, migration, dierentiation, survival and gene expression (reviewed in Giancotti and Ruoslahti, 1999; Turner, 2000a) . Integrin cytoplasmic domains lack known enzymatic activity and initiate signaling through association with non-receptor kinases including Integrin-linked Kinase, Focal Adhesion Kinase (FAK) and SRC family members, as well as a number of regulatory adaptor molecules including paxillin (Buckley et al., 1998; Glenney and Zokas, 1989; Turner et al., 1990) . Paxillin is a 68 kDa focal adhesion protein ®rst identi®ed as a prominent tyrosine phosphorylated protein in v-src transformed cells, and is one member in a family of three related adaptor proteins including the hematopoietic protein Leupaxin and Hic-5 (Buckley et al., 1998; Glenney and Zokas, 1989; Shibanuma et al., 1994; Turner, 2000a; Lipsky et al., 1998) .
Paxillin is a regulatory molecule that interacts with a variety of molecules that regulate the cytoskeleton, and is expressed at low levels compared to structural proteins such as vinculin and talin that couple integrins to the actin cytoskeleton (Turner et al., 1990) . The amino terminus of paxillin contains ®ve proteinbinding leucine rich motifs (LDXLLXDL), known as LD motifs, that are conserved among mammalian, avian, and Drosophila paxillin molecules (Brown et al., 1998a; Wheeler and Hynes, 2001) . LD1 can interact with a recently described protein called actopaxin that is implicated in cytoskeletal remodeling as well as ILK3, a serine threonine kinase homologous to Integrin Linked Kinase Turner, 2000, 2001) . LD2 and LD4 interact with FAK in cell lysates and mutation of both LD motifs is required to abrogate the interaction of paxillin with FAK (Brown et al., 1996; Thomas et al., 1999) . LD1, LD2 and LD4 can associate with the papillomavirus E6 protein and this interaction can compete for the binding sites on paxillin for FAK and vinculin (Tong et al., 1997; our unpublished observations; Vande Pol et al., 1998) . Paxillin has recently been found to associate with a number of ARF ± GAP proteins known to regulate both actin rearrangement and membrane tracking (Kondo et al., 2000; Mazaki et al., 2001; Norman et al., 1998) . The ARF ± GAP protein p95PKL binds to LD4, thereby linking paxillin to the serine/threonine kinase PAK1 that can regulate actin organization (Lu and Mayer, 1999; Turner et al., 1999) . Overexpression of activated ARF proteins causes co-localization of paxillin with speci®c ARF family members, and can cause paxillin recruitment to focal adhesions (Norman et al., 1998; Kondo et al., 2000) . A poly-proline rich domain in the amino terminus of paxillin may be a binding site for the SRC protein (Turner, 1998 (Turner, , 2000b . Upon cell attachment to the ECM, the FAK/SRC complex phosphorylates tyrosine residues at positions 31 and 118 providing binding sites for the CRK family of SH2-containing adaptor molecules (Igishi et al., 1999; Petit et al., 2000; Schaller and Parsons, 1994; Turner, 2000a) .
The carboxyl terminus of paxillin contains four zinc ®nger motifs known as LIM domains, one of which (LIM3) is necessary for the localization of paxillin to focal adhesions (Brown et al., 1996) . Paxillin LIM domains contain binding sites for proteins such as PTP ± Pest and ! and g tubulin (Angers-Loustau et al., 1999; Brown et al., 1996 Brown et al., , 1998b Brown and Turner, 1999; Cote et al., 1999; Herreros et al., 2000; Shen et al., 1998 Shen et al., , 2000 Turner, 1998 Turner, , 2000a . The LIM domains contain a number of serine/threonine residues that are phosphorylated upon cell adhesion to ®bronectin and growth factor stimulation. Serine and threonine phosphorylation of residues in LIM3 by as yet unidenti®ed kinases may regulate paxillin localization to focal adhesions (Brown et al., 1996 (Brown et al., , 1998b Brown and Turner, 1999; Turner, 1994) .
Paxillin associates with the Focal Adhesion Kinase (FAK), a 125 Kda non-receptor tyrosine kinase that is activated upon integrin ligation to immobilized ECM components (reviewed in Guan, 1997; Schaller and Parsons, 1994; Schlaepfer et al., 1999) . Overexpression of the carboxy terminal domain of FAK blocks the interaction of FAK and paxillin and inhibits FAK activation and cell spreading that is initiated upon cell attachment to the ECM (Richardson and Parsons, 1996) . For this reason, the association of FAK with paxillin has been implicated in the regulation of FAK activation. FAK contains an amino terminal regulatory domain, a central kinase domain and the c-terminal focal adhesion-targeting (FAT) domain that is responsible for FAK localization to focal adhesions (Guan, 1997; Schlaepfer et al., 1999; Schlaepfer and Hunter, 1996; Shen and Schaller, 1999) . The FAT domain of FAK is also responsible for the association of FAK with paxillin, although the association of FAK with paxillin may not be required for FAK localization to focal adhesions (Guan, 1997; Thomas et al., 1999) . FAK contains several tyrosine residues that are phosphorylated in response to cell spreading and growth factor signaling (Guan, 1997; Schlaepfer et al., 1999) . Tyrosine 397 is the major autophosphorylation site and this phosphorylated tyrosine can serve as a binding site for c-src with subsequent tyrosine phosphorylation of paxillin and FAK by the FAK/csrc complex. Phosphorylated tyrosine 925 is a binding site for the adaptor protein Grb2 thereby linking integrin signaling to the activation of ERK (Guan, 1997; Schlaepfer et al., 1999) .
Despite the association of FAK and paxillin, there is little direct evidence for the function(s) of paxillin in the cell. Paxillin has been shown to interact with a4 integrins and thereby reduce cell spreading of mouse embryonic ®broblasts on VCAM1; however, the exact mechanism for generating this phenotype is unclear (Liu et al., 1999) . Paxillin binds many signaling molecules and may therefore be involved in integrin signaling and membrane tracking. Adherent proliferative cell lines contain paxillin and determining the eect of overexpressed paxillin mutants is dicult due to the presence of the native protein. In this report, a paxillin null mouse ES cell was generated by targeted gene disruption. We ®nd that paxillin null ES cells have a defect in the early events of spreading on ®bronectin and laminin coated surfaces. Analysis of FAK tyrosine phosphorylation revealed that the paxillin null ES cells are de®cient for FAK tyrosine phosphorylation. These results demonstrate that paxillin facilitates the early events of cell spreading and FAK phosphorylation in ES cells.
Results

Targeted disruption of paxillin in ES cells
In order to better understand the role of paxillin in integrin signaling, we created a cell line in which both alleles of paxillin were deleted by targeted gene disruption as detailed in the Materials and methods. Oligonucleotides used to isolate paxillin genomic fragments and to screen ES cell colonies for homologous recombination between cellular paxillin gene and the targeting plasmid are shown in Figure 1 .
The paxillin targeting plasmid was electroporated into ES cells and drug resistant colonies were selected and screened in a process consisting of two separate PCR reactions. Oligonucleotide pair C/G generates a 2.8 kb band in any cell that has a wild type paxillin allele; this reaction serves as a positive control for the DNA preparation. Oligonucleotide pair F/G only generates a 2.4 kb product in ES cell colonies where the targeting vector has recombined homologously with the genome so that the neomycin gene is in proximity to oligonucleotide G (Figure 1 ).
Clone 17 is paxillin null
Using oligonucleotide pair F/G to screen for homologous recombination between the targeting plasmid and genomic DNA, clone 31 cells are haploid for paxillin (Figure 2a ). PCR reactions with oligonucleotide pair C/G showed that each of the colonies contained DNA that yielded a product in a PCR reaction. To con®rm the previous result, oligonucleotides H, I, F, and G ( Figure 1 ) were used in combination reactions with wild type and clone 31 cells. The wild type cells did not make product with any of the oligonucleotide pairs; however, the clone 31 cell line produced products with all the oligonucleotide pairs ( Figure 2b ). By this analysis clone 31 cells contain one paxillin allele deleted by targeted gene disruption. In order to select for disruption of the second paxillin allele, clone 31 cells were placed in high G418 to select for gene conversion and the resulting colonies were screened for a paxillin null genotype (see Materials and methods); after an event that disrupts both paxillin alleles, the binding site for oligonucleotide C should be lost, but the binding site for oligonucleotide F should remain. Screening of colonies after high-level drug selection by PCR revealed that clone 17 was paxillin null (Figure 2c ). The null phenotype was con®rmed by screening for paxillin protein expression on blots with equalized cell lysates from wild type, haploid and null cells; no truncated paxillin products resulted from gene targeting (Figure 2d ) while vinculin expression was the same from all samples (Figure 2d ). Clone 43 (paxillin +/7) cells were subjected to similar selection and growth conditions as clone 17 (paxillin 7/7) cells but remained +/-for paxillin, and therefore clone 43 and clone 17 cells were used in all subsequent assays for paxillin functions.
Western blot analysis of paxillin null ES cells
Disruption of the talin gene resulted in the loss of integrin b1 expression in ES cells (Priddle et al., 1998) . We therefore wanted to characterize the paxillin null cells for the loss of focal adhesion proteins. Equalized lysates from wild type, haploid clone 43 and paxillin null clone 17 were fractionated on SDS ± PAGE and blotted to PVDF membrane. The blots were probed with the indicated antibodies and all blots showed approximately equal levels for each protein investigated (Figure 3 ). ES cells and in vitro dierentiated cells derived from embryoid bodies were investigated for the presence of the paxillin related protein Hic-5. Wild type and paxillin null undierentiated ES cells show no detectable Hic-5 by Western blot analysis, even after prolonged exposure (Figure 3) . The in vitro dierentiated cells derived from the wild type, haploid and paxillin null cells show similar levels of Hic-5 ( Figure  3) . A 46 kDa paxillin band, which may represent a proteolytic, or internally initiated paxillin molecule is absent in the paxillin null cells (Figure 3 bottom panel) .
Spreading and attachment of ES cells on fibronectin
Wild type and paxillin null ES cells were evaluated for attachment and spreading. Clone 43 and clone 17 cells were plated onto ®bronectin-coated glass coverslips for 24 h. Compared to most dierentiated cells, ES cells spread slowly after attachment. The clone 43 haploid cells were partially spread 24 h after plating; however, the paxillin null clone 17 cells were mostly unspread at 24 h (compare Figure 4a Figure 4e . Clone 43 cells grew at a slightly faster rate and to a slightly higher density than the clone 17 cells (Figure 4e ).
The attachment and spreading dierence between clone 17 and clone 43 cells was quanti®ed in Figure 5 . While both paxillin null and paxillin expressing cell lines appeared to have approximately equal attachment to a ®bronectin-coated plastic surface (Figure 5a ), there were marked dierences in cell spreading. The wild type and paxillin haploid ES cells spread similarly after attachment, however the clone 17 cells were delayed in spreading ( Figure 5b ). Stable re-expression of wild type paxillin in the clone 17 null cells restored spreading to levels similar to that of wild type and haploid cells ( Figure 5b ). Similar results were observed with clone 43, clone 17, and paxillin reconstituted clone 17 cells plated onto laminin-coated plastic surfaces (data not shown). We used stably transfected clone 17 cells expressing paxillin mutants to recover spreading of the paxillin null cells plated onto ®bronectin-coated plastic surfaces for 1 h. All of the mutants that we tested were able to restore spreading ( Figure 6b ). The level of paxillin protein in the stable paxillin-transfected clone 17 cell lines is slightly less than that of the clone 43 haploid cells (Figure 5c, bottom) . In all of our experiments, ES cells spread more quickly on matrixcoated plastic surfaces than on matrix-coated glass coverslips, possibly due to the higher matrix binding capacity of plastic compared to glass (our unpublished observations). (Wiles, 1993) , resulting in the loss of the binding site oligonucleotide C. ES cells null for both alleles of paxillin will not make the 2.8 kb product with the C/G oligo pair since both copies of the wild type gene have been removed, but will make the expected 2.4 kb product for the F/G PCR reaction. This result is consistent with clone 17 cells being null for paxillin. (d) Paxillin protein expression in ES cell clones. Cell lysates from ES clones genotypicaly characterized by PCR as wild type +/+, haploid +/7 (31, 43, 55) and null 7/7 (17) were equalized for protein concentration, separated by SDS ± PAGE, and blotted to PVDF membrane. Duplicate blots were probed with antibodies to paxillin (top) and vinculin (bottom). Clone 17 cells do not express paxillin In order to determine if transient paxillin expression in clone 17 cells would result in enhanced cell spreading, clone 43 and paxillin-null clone 17 cells were transiently cotransfected with plasmids to express wild type paxillin or paxillin mutants together with green¯uorescent protein (GFP). Twenty-four hours after transfection, cells were trypsinized and replated onto ®bronectin-coated glass coverslips for an additional 8 h. Approximately 60% of clone 43 cells were spread at 8 h ( Figure  6a ). Less than 10% of the clone 17 paxillin null cells were spread at 8 h post plating (Figure 6a ). The spreading defect was substantially restored in clone 17 cells transfected with plasmids expressing the 46 kDa molecule (paxillin amino acids 133 ± 559) or wild type paxillin (Figure 6a ). The 46 kDa paxillin molecule is deleted of LD1, the amino-terminal poly-proline region and SH2 binding motifs at amino acids 31, and 118. In contrast, neither paxillin amino acids 1 ± 331 (deleted of the LIM domains) nor the paxillin LIM domains either alone or together restored cell spreading (Figure 6a ). Expression of paxillin was con®rmed by Western blot ( Figure 6b) ; the LIMS only domain was expressed at very low levels (and is not evident in the Figure 6 Western blot), and the 1 ± 331 domain of paxillin is not recognized by the monoclonal antibody used in the experiment.
Reduced tyrosine phosphorylation of FAK in paxillin null cells
Because paxillin binds a FAK/SRC complex and paxillin has been implicated in the regulation of FAK and SRC functions, we examined cell lysates for tyrosine phosphorylation. Equalized protein lysates from wild type, clone 17 and clone 43 cells were separated by SDS ± PAGE, transferred to PVDF membrane, and probed with an antibody against phosphotyrosine. The wild type and haploid lanes showed similar banding patterns; however, the paxillin null cells showed reduced tyrosine phosphorylation of bands at approximately 125 kDa and 205 kDa (Figure 7) .
The loss of tyrosine phosphorylated bands at 125 kDa suggested that FAK might be reduced for phosphotyrosine; therefore equalized protein lysates from clone 43 and 17 ES cells were immunoprecipitated for FAK and separated by SDS ± PAGE. Duplicate gels were transferred to PVDF, one probed for phosphotyrosine, the other for FAK. The wild type, clone 43, and clone 17 cells had very similar levels of FAK protein; however, the clone 17 cells showed markedly decreased levels of FAK tyrosine phosphorylation (Figure 8a ). The decreased FAK phosphotyrosine in clone 17 cells was reversed by stable re-expression of wild type paxillin (Figure 8a ). FAK tyrosine phosphorylation was restored in clone 17 cell lines expressing the paxillin L7A mutant and the amino-terminally truncated 46 kDA molecule (amino acids 133 ± 559) (Figure 8b) . Expression of the amino terminus alone (amino acids 1 ± 331) was not able to recover FAK tyrosine phosphorylation (Figure 8b) . Expression of paxillin mutants deleted of individual LD motifs LD1, LD3, LD4, and LD5 restored FAK tyrosine phosphorylation (Figure 8c and data not shown). Our studies indicate that paxillin tyrosine residues 31, 33, 40 and 118, as well as LD1, LD3, LD4 and LD5 and the amino terminal proline rich region are individually dispensable for FAK tyrosine phosphorylation in ES cells (Figure 9 ). Paxillin molecules deleted of LD2 were unstable in ES cell expression (data not shown). Comparison of immunoprecipitated pp120, p130 CAS, CRK, SRC and PYK2 from clone 43 and clone 17 ES cell lysates revealed equal protein levels and phosphotyrosine content by Western blot analysis (data not shown).
Discussion
To further our understanding of the role of paxillin in integrin signaling, we used targeted gene disruption to create a paxillin null cell line. Clone 17 ES cells do not express detectable levels of paxillin or Hic-5 by Western blot. This is in contrast to the dierentiated cells derived from the clone 17 ES cells that express Hic-5 (Figure 3 and our unpublished observations on dierentiated cell lines derived from clone 17 ES cells). Figure 5 is due to the use of glass versus plastic matrix coated surfaces; spreading is considerably faster on plastic surfaces. In addition to delayed kinetics of cell spreading, the paxillin null cells show a reduction in FAK tyrosine phosphorylation.
Signaling from integrins can feed back and alter the anity of integrins for the matrix (reviewed in Tozer et al., 1996) . The clone 17 paxillin null cells attach equally as well as wild type cells, suggesting that signaling needed by ES cells for initial attachment to a surface does not require paxillin. Once the cell has engaged the surface, tyrosine kinase dependent signaling results in reorganization of the actin cytoskeleton and cell spreading (reviewed in Feller et al., 1998; Giancotti, 1997; Lewis and Schwartz, 1998) . The paxillin null clone 17 cells show a delayed spreading onto ®bronectin and laminin coated surfaces. This result indicates that paxillin is involved in generating or transmitting the signals that coordinate cell spreading. Forty-eight hours after plating, paxillin null cells appear fully spread and similar to the wild type cells. In the ES cell culture a subpopulation of cells are large and spread quickly in both the wild type and clone 17 These results indicate that there may be dierent mechanisms that can promote cell spreading in ES cells. The large cells can spread rapidly in a paxillin independent manner, possibly due to the expression of Hic-5 or another compensatory molecule. The small ES cells require paxillin for ecient cell spreading; however given sucient time the paxillin null cells spread on the ®bronectin coated surface. The delay in spreading of paxillin null cells indicates paxillin may act as a catalyst in transmitting the signal for a cell to reorganize the actin cytoskeleton and spread onto a surface. Another possibility is that the attached but as yet unspread paxillin null ES cells may adapt to permit paxillin independent cell spreading over the subsequent 48 h.
Re-expression of paxillin by transient or stable transfection restores the spreading defect in paxillin null cells. The wild type and 46 kDa paxillin mutant were both able to facilitate spreading to a similar extent when re-expressed in paxillin null cells. The 46 kDa mutant is deleted of LD1, a proline-rich tract, and tyrosines 31, 33, 40 and 118. This mutant cannot associate with CRK proteins through the known CRK binding sites at tyrosines 31 and 118 (Birge et al., 1993) . This would imply that interaction with SH2 proteins at these tyrosine residues is not necessary for paxillin facilitated cell spreading in ES cells. We observed equal levels of CRK protein and tyrosine phosphorylated CRK protein in the paxillin null versus wild type ES cells, indicating that overall basal tyrosine phosphorylation of CRK is not paxillin dependent in ES cells (data not shown). The LIMS only domain was expressed at very low levels by Western blot (data not shown). The paxillin 1 ± 331 mutant was unable to restore cell spreading in ES cells. This mutant is missing the LIM domains and may be unable to properly localize to focal adhesions. Future studies with additional paxillin mutants will be needed to elucidate the regions of paxillin that facilitate cell spreading. Since clone 17 cells are reduced for both early cell spreading and FAK tyrosine phosphorylation it is possible that tyrosine phosphorylation of FAK mediates paxillin induced cell spreading in ES cells; however this is not proven in our studies. Interestingly, deletion of paxillin LD4 did not abrogate paxillin dependent cell spreading. In addition to binding FAK, LD4 is the binding site for the ARF ± GAP protein p95PKL that can complex paxillin with the GEF protein PIX and thereby the serine threonine kinase PAK1 . Other ARF ± GAP proteins bind the paxillin amino terminus; however, the exact binding sites have not been described (Kondo et al., 2000) . Association of other ARF family members on dierent sites on paxillin may be able to substitute for the loss of the paxillin/p95PKL complex.
FAK is comprised of three primary domains, an amino terminal regulatory, a central catalytic, and a carboxyl terminus Focal Adhesion Targeting (FAT) domain. The FAT domain is the region necessary for targeting to focal adhesions and binding to talin and paxillin (Hildebrand et al., 1993 (Hildebrand et al., , 1995 . FAK targeted to the membrane using either a FAK/vinculin chimera or a myristoylation tag is tyrosine phosphorylated (Igishi et al., 1999; Shen and Schaller, 1999) . FAK can be activated in response to growth factors as well as integrin signaling, resulting in the phosphorylation of site 397 as well as the phosphorylation of tyrosines 576/577 and 925 by the SRC proteins (Guan, 1997; Schlaepfer et al., 1999) . Activation of FAK results in an increase in cell spreading, reduced motility and protection from apoptosis (Schlaepfer et al., 1999; Shen and Schaller, 1999) . The phosphorylation of FAK may not coincide with the kinase activity of FAK and discerning between the eects of kinase activity of FAK and FAK-associated SRC in the cell can be dicult (Schlaepfer et al., 1999) . This is observed in serum-starved ®broblasts where tyrosine phosphorylated FAK has a low in vitro kinase activity. Once the starved cells are placed in serum containing media and plated onto ®bronectin there is an increase in FAK kinase activity as well as an association of FAK with SRC (Schlaepfer et al., 1999) . One model of FAK activation suggests that FAK complexes with the integrin intracellular domain, but FAK may be folded in an inactive conformation (Guan, 1997; Schlaepfer et al., 1999) . After integrin activation, a conformational change in FAK would enable kinase activation, autophosphorylation, and association with SRC. The role of paxillin in such a model of FAK activation is not clear.
We show that FAK tyrosine phosphorylation occurs without the individual motifs LD1, 3, 4 and 5. The anity of FAK for the individual LD motifs 2 and 4 is approximately equal with a cooperative eect when both LD motifs are present . Our data indicate that, if the interaction of FAK with paxillin is required for FAK activation, then the association of FAK with paxillin LD2 alone may support tyrosine phosphorylation of FAK. Paxillin molecules deleted in LD2 or containing point mutations in LD2 were unstable in our experiments in ES cells. Further mutational analysis of LD2 will be needed to generate a paxillin mutant that does not bind FAK at either LD2 or LD4 and can be expressed stably in these cells. Such a paxillin molecule will be necessary to determine if FAK binding to paxillin LD motifs is necessary for FAK tyrosine phosphorylation and cell spreading in ES cells.
FAK activation may involve FAK binding to paxillin, thereby inducing a conformational change in FAK that facilitates FAK tyrosine phosphorylation. The association of FAK with paxillin may be required to correctly localize FAK in focal adhesions. Another possibility would be that paxillin brings substrates to activated FAK, and that tyrosine phosphorylation of FAK may not be sucient to support cell spreading. If paxillin brings substrates to FAK, it is conceivable that mutants of paxillin could be made that might restore FAK phosphorylation but would not support spreading. The phosphorylation status of individual tyrosines of FAK in clone 17 and clone 43 cells is under investigation and may help distinguish among these possibilities. Further mutational analysis of FAK and paxillin will be necessary to elucidate mechanism used by paxillin in cell spreading.
Materials and methods
Paxillin targeting construct
Mouse paxillin genomic DNA regions that were used for homologous recombination were isolated using long range PCR and the fragments were cloned into the pPNT targeting vector (Matise et al., 2000; Tybulewicz et al., 1991) . Portions of the mouse paxillin gene were isolated by PCR and cloned 5' and 3' to the neomycin resistance gene to generate a paxillin gene targeting plasmid. Sequence from a mouse paxillin partial cDNA in the EST database was used to generate oligonucleotides C and D (Figure 1) . This oligonucleotide and a poly dT primer were used in a reverse transcription PCR reaction to isolate a partial mouse paxillin cDNA. Oligonucleotides E, I, and G ( Figure 1) were synthesized based on the sequence from the 3' end of the paxillin cDNA. Oligonucleotide pair D/E was used in a PCR reaction with mouse ES cell DNA to amplify a 2.2 kb band containing exons 10 through the 3'UTR from 129Sv genomic DNA. This band was cloned 3' to the neomycin resistance gene in the targeting plasmid pPNT (Tybulewicz et al., 1991) .
Oligonucleotide B was based on the 5' end of the mouse paxillin EST sequence. In order to amplify a region of genomic DNA within the 5' portion of the paxillin gene, oligonucleotide A was designed based on a region of human and chicken sequence that was well conserved at the nucleic acid level. Oligonucleotide pair A/B was used to amplify a 2 kb segment of the paxillin gene from mouse ES cell genomic DNA encoding exon 2 to exon 6. This band was cloned into the targeting plasmid containing the paxillin 3' genomic DNA segment D/E (Figure 1) . Homologous recombination between the targeting plasmid and genomic DNA is predicted to delete exons corresponding to amino acids 225 ± 404 of the paxillin a protein.
Oligonucleotides B, C and D were generated against mouse genomic DNA based on sequence available from mouse EST sequence (Genbank AA644797). Oligonucleotide D (Figure 1 ) and a poly dT primer were used in a reverse transcription reaction (Superscript, Gibco BRL) to generate a mouse cDNA of the 3'UTR of paxillin; oligonucleotides E, G and I were generated from that sequence. The 2.4 kb 3' homology region in Figure 1 was generated using oligonucleotide pair D/E in a PCR reaction (Expand Long Template PCR system, Boehringer Mannheim) with mouse 129Sv genomic DNA as template. To generate the 5' homology region, oligonucleotide A (AGAGGTACCgccctgctggcggacttggagtctaccacc) was created using a combination of chicken and human sequence. The oligonucleotide pair A/B were used in a PCR reaction with mouse 129Sv genomic DNA to generate the 2.2 kb 5' homology region. This PCR fragment was cloned into the pPNT vector that had the 3' homology region cloned in previously.
ES cell culture
The R1 line of ES cells (Nagy et al., 1993) was grown in Iscove media supplemented with 20% FBS (Gibco BRL), 1 mM Amino Acids (Life Technologies), 10 mM b Mercaptoethanol (Sigma) and Penicillin/Streptomycin (Life Technologies) essentially as described (Matise et al., 2000) . Fetal calf serum lots were screened to exclude serum that induced dierentiation markers. A Leukemia Inhibitory Factor (LIF) GST fusion plasmid was expressed in E. Coli. and puri®ed using GSH beads and the LIF cleaved from the GST using thrombin. The LIF preparation was sterile ®ltered and tested for the ability to suppress ES cell dierentiation before use. ES cells were grown on tissue culture plates coated with 0.1% gelatin (Sigma). ES cells were dierentiated in vitro to form embryoid bodies as described (Wiles, 1993) .
Electroporation and selection of colonies in ES cells
Linearized targeting vector DNA was prepared as described and electroporated into ES cells (Matise et al., 2000) . Twenty-four hours after plating, G418 (Life Technologies) at 200 mg/ml and Gancyclovir at 0.2 mM were added to the media. Ten days after selection a sterile cotton applicator wetted with trypsin was used to transfer drug resistant ES colonies from the plate into wells of a 24 well plate. Each plate was duplicated and one plate used to prepare genomic DNA. To select for a duplication of the neomycin gene and deletion of the remaining wild type paxillin allele, haploid cells were placed in a range of G418 concentrations from 0.8 mg/ml to 2 mg/ml as described (Mortensen et al., 1992) . Colonies selected from 1 mg/ml wells were isolated as above and screened by PCR to determine that both alleles of paxillin had been disrupted and screened by Western blot for loss of paxillin protein expression.
Screening for paxillin haploid ES colonies
Drug resistant ES clones were screened in two separate PCR reactions. Oligonucleotides F and H were generated using sequence from the neomycin cassette in the pPNT targeting vector. A PCR reaction using oligonucleotide pair F/G yields a 2.4 kb product only in a colony where the homologous recombination event between the targeting vector and the paxillin gene inserts the neomycin resistance cassette in proximity to oligonucleotide G. No product will be made in a non-homologously recombined colony. A PCR reaction with oligonucleotide pair C/G yields a 2.8 kb fragment from all colonies. PCR reactions were performed in a 96 well plate using Expand Long Template PCR kits (Boehringer Mannheim) in a Hybaid PCR express machine. For all PCR reactions with oligos F, G, H and I, a positive control plasmid (+ lanes in Figure 2a,c) was made by cloning the mouse paxillin cDNA fragment generated by the oligo D/dT PCR reaction into the pPNT targeting vector. This plasmid was electroporated into ES cells and a cell line containing the + plasmid was selected. Genomic DNA preparations were prepared as above and samples of this DNA was used as a positive control (indicated by + marking above the lane). The PCR product from oligos F/G from this + positive control DNA will be around 1.4 kb since it is generated from a spliced cDNA. This control cell line was created as a positive control for the PCR reaction itself, and to insure that PCR products observed from ES colonies with putative knockout recombination events were truly a result of a homologous recombination knockout and not due to contamination of the ES colony DNA preparation with either the positive control DNA sample ('+' DNA sample) or paxillin cDNA plasmids present in the laboratory.
Paxillin vectors and transfection
The vector pCX-EGFP with EGFP replaced by a multiple cloning site was used for paxillin expression in ES cells (Okabe et al., 1997) . The wild type paxillin and 1 ± 331 mutant (expresses paxillin amino acids 1 ± 331) were gifts of Chris Turner (Brown et al., 1996) . Oligonucleotide directed mutagenesis was used to generate all point mutants and LD deletion mutants. LD1-, LD3-, LD4-and LD5-are deleted of amino acids 4 ± 11, 218 ± 225, 267 ± 274 and 302 ± 310 respectively. DNA was introduced in the ES cells using the Lipofectamine Plus reagent (Life Technologies). For stable expression, paxillin plasmids were cotransfected with the PGK-Puro plasmid (Tucker et al., 1996) and cells were selected in 2 mg/ml puromycin (Life Technologies). Stable cell lines were screened for paxillin expression by Western blot.
Attachment and spreading assays were performed essentially as described (Humphries, 1998) . Twenty-four well tissue culture plates were coated with puri®ed matrix proteins for 5 min and allowed to dry overnight before being blocked with a 1 mg/ml treated killed BSA solution. Trypsinized, washed and resuspended ES cells were counted and 5x10 5 cells were plated in each of six wells. After incubation, the media from three wells for each cell line was aspirated, and the wells were ®xed in 10% formaldehyde for 10 min. The remaining three un®xed wells were washed three times to remove unattached cells with phosphate buered saline and then ®xed for 10 min. After ®xation, all wells were rinsed with PBS and stained in a 0.1% crystal violet in MES (2(Nmorpholino) ethanesulfonic acid) buer for 16 h at 48C. The stained wells were washed three times with water, allowed to dry, and cells were observed under the microscope and counted as spread if the total cell body width was at least twice that of the nucleus. This same standard we used for all spreading assays. After enumeration of spread cells, the crystal violet was dissolved in 10% acetic acid and the absorbance read on a Beckman DU 64 Spectrophotometer at 570 nm to determine the relative number of attached cells (Humphries, 1998) . The absorbance of the three washed wells was averaged and divided by the average value for the unwashed wells to give the per cent retained after washing. Each spreading assay was repeated three times.
The growth curves for clone 43 and clone 17 cells were performed on gelatin coated plates. 1x10 5 cells were plated onto ®ve identical 6 cm tissue culture plates. Plates were ®xed and stained with crystal violet as above.
To assess attachment and spreading of transiently transfected cells, ES cells were transiently cotransfected with the indicated paxillin expressing vectors and the pCX ± EGFP plasmid. Twenty-four hours after transfection cells were trypsinized and replated on puri®ed matrix coated cover slips for 8 h. Cells were ®xed, nuclei were DAPI stained, and GFP positive cells were scored for spreading by¯uorescence microscopy.
Antibodies and Western analysis
Cells were lysed on ice in NP40 lysis buer (150 mM NaCl; 50 mM Tris pH 7.5; 50 mM NaF; 5 mM NaPPi; 1% IPEGAL; 0.01% phenylmethylsulfonyl¯uoride; 1 mM Sodium Vanadate; 1 mg/ml Leupeptin/Aprotinin). Lysates were equalized for protein content using the Bio-Rad Protein Assay solution (Bio-Rad). Cells used for phosphotyrosine assays were plated onto gelatin coated plates 24 h before lysis, no morphological dierences were observed under these conditions. Immunoprecipitations were prepared using 0.5 mg of protein and 1 mg of puri®ed antibody. The complex that formed on ice for 1 h was precipitated using Rabbit anti mouse IgG and protein A sepharose beads (Repligen), and rocked at 48C for 1 h. Beads were washed three times with 1.5 ml lysis buer and complexes were eluted in SDS loading buer (2% SDS, 60 mMTris pH 6.8, 100 mM dithiothreitol, 2.5% glycerol, 0.01% bromophenol blue).
Antibodies to paxillin, integrin b1, pp120, Pyk2, Hic5 were all from Transduction Laboratories. The antibodies to vinculin and phosphotyrosine (clone 4G10) were from Sigma and Upstate Biotechnology respectively. Integrin alpha V antibody was a rabbit polyclonal from Chemicon. Antibodies for FAK Western blots and immunoprecipitations were from Transduction Labs and Upstate Biotechnology respectively. Primary antibodies on Western blots were detected utilizing horseradish peroxidase conjugated secondary antibodies and Supersignal substrate solution (Pierce).
